Complete Filing Data
TRINITY BIOTECH PLC reported Selling General And Administrative Expense of $28.82 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean TRINITY BIOTECH PLC did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Selling General And Administrative Expense | $28.8M | $31.2M | $27.0M | $22.5M | $26.4M | $27.7M | $29.5M | $32.2M | $30.4M | $28.2M |
| Research And Development Expense | $4.5M | $4.4M | $4.1M | $4.5M | $5.1M | $5.3M | $5.4M | $5.7M | $5.0M | $5.1M |
| Profit Loss From Operating Activities | -$21.2M | -$27.0M | -$19.3M | $3.9M | $82.0K | -$24.1M | -$20.2M | -$37.7M | -$39.8M | $13.5M |
| Profit Loss Before Tax | -$30.7M | -$36.9M | -$43.8M | -$1.9M | -$6.6M | -$30.0M | -$23.2M | -$39.9M | -$42.1M | $22.9M |
| Profit Loss | -$31.2M | -$36.9M | -$43.6M | -$1.9M | -$6.0M | -$29.0M | -$22.7M | -$38.7M | -$38.6M | $22.2M |
| Income Taxes Paid Refund Classified As Operating Activities | -$1.0M | -$312.0K | $15.0K | -$1.6M | $972.0K | $18.0K | $416.0K | -$843.0K | -$1.2M | -$463.0K |
| Income Tax Expense Continuing Operations | $486.0K | -$59.0K | -$194.0K | -$74.0K | -$620.0K | -$1.0M | -$525.0K | -$1.2M | -$3.6M | $756.0K |
| Gross Profit | $21.4M | $19.5M | $17.3M | $33.5M | $48.6M | $38.1M | $41.4M | $41.9M | $43.5M | $46.5M |
| Cost Of Sales | $40.1M | $37.4M | $45.3M | $47.7M | $53.4M | $52.3M | $55.6M | $57.3M | $56.1M | $53.7M |
| Profit Loss Attributable To Owners Of Parent | -$31.8M | -$24.0M | -$41.0M | $875.0K | -$6.4M | -$28.9M | -$22.1M | -$40.3M | -$100.6M | $21.8M |
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation | $245.0K | $69.0K | -$396.0K | -$86.0K | -$1.4M | -$167.0K | -$520.0K | $3.1M | $3.1M | -$4.9M |
| Other Comprehensive Income | $245.0K | $69.0K | -$396.0K | -$86.0K | -$1.4M | -$167.0K | -$520.0K | $3.1M | $3.1M | -$4.9M |
| Comprehensive Income Attributable To Owners Of Parent | -$31.5M | -$23.9M | -$41.4M | $789.0K | -$7.7M | -$29.1M | -$22.6M | -$37.2M | -$97.5M | $16.9M |
| Adjustments For Income Tax Expense | $486.0K | -$59.0K | -$192.0K | -$167.0K | -$182.0K | -$1.0M | -$1.1M | -$374.0K | -$8.6M | $1.1M |
| Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | $1.4M | $11.1M | $5.8M | $6.9M | $17.8M | $24.3M | $26.9M | $41.8M | $48.2M | |
| Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss Trade And Other Receivables | $0.00 | $0.00 | $482.0K | $583.0K | $562.0K | $1.4M | $1.6M | $1.7M | $757.0K | |
| Profit Loss From Discontinued Operations | -$573.0K | $12.9M | $2.6M | $2.7M | -$375.0K | $77.0K | $568.0K | -$1.6M | -$62.0M | |
| Impairment Loss Recognised In Profit Or Loss Intangible Assets Other Than Goodwill | $1.6M | $5.8M | $4.6M | $3.9M | $15.4M | $16.6M | $19.2M | $29.7M | $87.7M | |
| Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss Property Plant And Equipment | $612.0K | $3.8M | $733.0K | $2.5M | $1.8M | $6.3M | $6.1M | $10.4M | $9.0M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flows From Used In Operating Activities | -$4.2M | -$11.6M | -$921.0K | $13.2M | $23.8M | $5.4M | $7.2M | $9.3M | $10.2M | $13.2M | |
| Cash Flows From Used In Financing Activities | $28.8M | -$16.0M | -$12.3M | -$6.0M | -$2.7M | -$7.5M | -$16.9M | -$12.6M | -$13.4M | $107.5M | |
| Cash And Cash Equivalents | $5.2M | $3.7M | $6.6M | $25.9M | $27.3M | $15.2M | $30.3M | $57.6M | $77.1M | $102.0M | $9.1M |
| Cash And Cash Equivalents And Short Term Investments | $5.2M | $3.7M | $6.6M | $25.9M | $27.3M | $16.4M | $30.3M | $57.6M | |||
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $405.0K | $803.0K | $1.1M | $1.8M | $3.2M | $2.1M | $7.5M | $4.8M | $4.2M | $7.1M | |
| Purchase Of Intangible Assets Classified As Investing Activities | $9.7M | $1.9M | $4.9M | $6.9M | $7.0M | $9.7M | $9.9M | $10.2M | $16.5M | $19.5M | |
| Cash Flows From Used In Operations Before Changes In Working Capital | -$9.3M | -$9.2M | $754.0K | $17.4M | $25.6M | $8.2M | $13.4M | $9.5M | $12.2M | $20.0M | |
| Cash Flows From Used In Operations | -$5.2M | -$11.9M | -$908.0K | $11.6M | $24.7M | $5.9M | $6.0M | $9.4M | $10.6M | $13.5M | |
| Cash Flows From Used In Investing Activities | -$23.0M | $24.8M | -$6.0M | -$8.7M | -$10.2M | -$11.9M | -$17.4M | -$16.2M | -$21.9M | -$27.7M | |
| Trade And Other Current Receivables | $16.1M | $13.9M | $15.8M | $16.1M | $22.7M | $21.0M | $24.4M | $20.7M | $22.6M | ||
| Trade And Other Current Payables To Trade Suppliers | $26.8M | $12.8M | $15.4M | $15.1M | $24.3M | $16.9M | $16.9M | $20.5M | $24.8M | ||
| Retained Earnings | -$79.1M | -$48.6M | -$26.7M | $12.6M | $10.6M | $16.1M | $55.3M | $75.8M | $110.4M | ||
| Property Plant And Equipment | $4.6M | $1.9M | $5.7M | $5.9M | $8.5M | $9.3M | $5.4M | $5.8M | $13.4M | ||
| Other Noncurrent Financial Assets | $28.0K | $79.0K | $139.0K | $207.0K | $355.0K | $485.0K | $558.0K | $771.0K | $870.0K | ||
| Noncurrent Liabilities | $106.4M | $68.3M | $76.9M | $18.7M | $105.6M | $106.9M | $90.0M | $106.5M | $115.6M | ||
| Noncurrent Assets | $62.2M | $20.4M | $45.4M | $46.2M | $47.1M | $59.7M | $65.0M | $80.4M | $116.1M | ||
| Liabilities | $138.5M | $83.4M | $94.3M | $119.2M | $132.6M | $126.4M | $107.6M | $127.8M | $140.9M | ||
| Intangible Assets And Goodwill | $51.3M | $16.3M | $35.3M | $36.0M | $33.9M | $43.7M | $53.0M | $64.8M | $87.3M | ||
| Equity And Liabilities | $103.3M | $59.4M | $92.1M | $118.9M | $130.4M | $131.1M | $151.7M | $193.0M | $249.6M | ||
| Deferred Tax Liabilities | $4.6M | $2.3M | $5.1M | $4.9M | $4.9M | $7.1M | $7.9M | $10.8M | $18.4M | ||
| Deferred Tax Assets | $3.6M | $2.0M | $4.2M | $4.1M | $4.2M | $6.3M | $6.1M | $8.7M | $14.6M | ||
| Current Tax Liabilities Current | $364.0K | $279.0K | $28.0K | $22.0K | $154.0K | $48.0K | $210.0K | $310.0K | $175.0K | ||
| Current Tax Assets Current | $518.0K | $1.5M | $1.8M | $1.5M | $3.1M | $2.0M | $1.6M | $1.4M | $1.2M | ||
| Current Liabilities | $32.1M | $15.0M | $17.3M | $100.5M | $27.1M | $19.4M | $17.6M | $21.2M | $25.3M | ||
| Current Assets | $41.1M | $39.0M | $46.7M | $72.7M | $83.3M | $71.4M | $86.7M | $112.6M | $133.5M | ||
| Assets | $103.3M | $59.4M | $92.1M | $118.9M | $130.4M | $131.1M | $151.7M | $193.0M | $249.6M | ||
| Adjustments For Increase Decrease In Trade And Other Payables | $8.2M | -$2.8M | $181.0K | -$7.6M | $5.0M | $151.0K | -$3.4M | $2.0M | $1.3M | -$3.3M | |
| Adjustments For Gain Loss On Disposals Property Plant And Equipment | $0.00 | $0.00 | -$2.0K | $1.0K | -$30.0K | -$17.0K | -$15.0K | -$3.0K | -$15.0K | -$15.0K | |
| Adjustments For Decrease Increase In Trade And Other Receivables | -$2.4M | $1.0M | -$966.0K | $6.2M | -$2.5M | $445.0K | -$6.0M | $306.0K | $682.0K | -$772.0K | |
| Noncurrent Derivative Financial Liabilities | $1.7M | $526.0K | $1.6M | $0.00 | $1.4M | $4.0K | $238.0K | $2.2M | $4.3M | ||
| Noncurrent Derivative Financial Assets | $166.0K | $178.0K | $128.0K | $0.00 | $150.0K | $360.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Cash And Cash Equivalents | $1.7M | -$2.8M | -$19.2M | -$1.5M | $10.8M | -$14.0M | -$27.0M | -$19.6M | -$25.0M | $93.0M |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -$175.0K | -$44.0K | -$112.0K | $55.0K | $86.0K | $88.0K | -$296.0K | $71.0K | $158.0K | -$127.0K |
| Payments Of Lease Liabilities Classified As Financing Activities | $2.5M | $2.3M | $2.8M | $2.9M | $3.2M | $3.5M | $374.0K | $295.0K | ||
| Proceeds From Issuing Shares | 7.4M | 0.00 | 25.3M | 0.00 | 0.00 | 857.0K | 2.9M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Other Operating Income Expense | -$1.8M | $141.0K | $343.0K | $4.4M | $1.9M | $91.0K | $102.0K | $100.0K | $239.0K | $288.0K |
| Net Financing Expense Income | -$9.6M | -$9.9M | -$24.4M | -$5.9M | -$6.7M | -$5.9M | -$3.0M | -$2.2M | -$2.3M | $9.4M |
| Finance Income | $0.00 | $1.2M | $303.0K | $1.2M | $36.0K | $697.0K | $2.1M | $3.2M | $3.1M | $13.5M |
| Finance Costs | $9.6M | $11.1M | $24.7M | $7.1M | $6.8M | $6.6M | $5.1M | $5.4M | $5.4M | $4.1M |
| Adjustments For Sharebased Payments | $1.3M | $2.1M | $1.8M | $1.1M | $792.0K | $758.0K | $1.4M | $928.0K | $1.4M | $1.6M |
| Other Adjustments For Noncash Items | $2.5M | $257.0K | $269.0K | -$5.3M | -$634.0K | $835.0K | $570.0K | -$728.0K | $4.1M | $563.0K |
| Interest Paid Classified As Financing Activities | $8.0K | $8.0K | $1.3M | $4.0M | $4.0M | $4.0M | $4.5M | $4.6M | $4.6M | $2.2M |
| Increase Decrease Through Sharebased Payment Transactions | $1.3M | $2.1M | $1.8M | $1.1M | $816.0K | $839.0K | $1.6M | $1.1M | $1.7M | $2.0M |
| Adjustments For Unrealised Foreign Exchange Losses Gains | $1.0M | $238.0K | -$76.0K | -$251.0K | -$663.0K | -$93.0K | $311.0K | $307.0K | -$226.0K | -$2.1M |
| Adjustments For Finance Income | $0.00 | $1.2M | $303.0K | $1.2M | $36.0K | $697.0K | $2.1M | $3.2M | $3.1M | $13.5M |
| Adjustments For Finance Costs | $9.6M | $11.1M | $24.7M | $7.1M | $6.8M | $6.6M | $5.1M | $5.4M | $5.4M | $4.1M |
| Adjustments For Depreciation Expense | $675.0K | $831.0K | $1.4M | $1.8M | $1.7M | $2.5M | $1.3M | $1.9M | $3.2M | $3.0M |
| Adjustments For Amortisation Expense | $1.2M | $946.0K | $923.0K | $917.0K | $1.4M | $2.4M | $2.8M | $3.3M | $3.0M | $2.7M |
| Interest Received Classified As Operating Activities | $0.00 | $0.00 | $2.0K | $1.0K | $104.0K | $560.0K | $874.0K | $776.0K | $901.0K | $135.0K |
| Share Premium | $63.4M | $46.6M | $46.5M | $16.2M | $16.2M | $16.2M | $16.2M | $16.2M | $16.2M | |
| Other Reserves | $23.0K | $23.0K | $86.0K | $23.0K | $23.0K | $23.0K | $23.0K | $23.0K | $4.6M | |
| Issued Capital | $4.2M | $2.0M | $2.0M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | |
| Inventories | $19.4M | $19.9M | $22.5M | $29.1M | $30.2M | $32.0M | $30.4M | $32.8M | $32.6M | |
| Current Provisions | $2.5M | $50.0K | $50.0K | $50.0K | $416.0K | $50.0K | $50.0K | $50.0K | $75.0K | |
| Adjustments For Provisions | $2.1M | $2.3M | $7.4M | $5.6M | $5.1M | $1.6M | $300.0K | $2.3M | -$533.0K | $852.0K |
| Adjustments For Decrease Increase In Inventories | -$1.7M | -$971.0K | -$877.0K | -$4.4M | -$3.4M | -$3.0M | $2.0M | -$2.5M | -$3.6M | -$2.3M |
| Interest Paid Classified As Operating Activities | $0.00 | $0.00 | $11.0K | $48.0K | $1.0M | $39.0K | $53.0K | $60.0K | $34.0K | |
| Treasury Shares | 24.9M | 24.9M | 24.9M | 24.9M | 24.9M | 24.9M | 24.9M | 24.8M | 17.3M | |
| Reserve Of Exchange Differences On Translation | -$5.5M | -$5.7M | -$5.8M | -$5.4M | -$5.3M | -$3.9M | -$3.8M | -$3.2M | -$6.3M |
Most recent annual filing with the SEC: May 16, 2025
Data sourced from SEC EDGAR public filings as of August 4, 2026.